Characteristics of seven CTEPH patients and psychological distress
| ID | Age (years) | Sex | Treatment | Side effects | Mean PAP | WHO-FC | All-day oxygen | PHQ-9 score | GAD-7 score |
| G | 70s | F | Oral | None | 53 | III | + | 12 | 2 |
| H | 70s | F | Oral | None | 25 | II | + | 15 | 4 |
| I | 50s | F | Post-BPA | None | 24 | II | – | 11 | 2 |
| J | 60s | F | Oral | Headache | 31 | II | + | 14 | 11 |
| K | 70s | F | Oral | None | 31 | III | + | 13 | 6 |
| L | 60s | F | Ongoing-BPA | None | 51 | III | + | 13 | 9 |
| M | 50s | M | Oral | None | 42 | III | – | 19 | 6 |
| Mean36.7 SD12.0 | Mean13.9 SD2.6 | Mean6.9 SD3.3 | |||||||
BPA, balloon pulmonary angioplasty; CTEPH, chronic thromboembolic pulmonary hypertension; GAD-7, 7-item Generalised Anxiety Disorder questionnaire; PAP, pulmonary arterial pressure; PHQ-9, 9-item Patient Health Questionnaire; WHO-FC, WHO-Functional Class.